This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bahner, I. Articles by Kohn, D. B. Search for Related Content PubMed PubMed Citation Articles by Bahner, I. Articles by Kohn, D. B.

 Previous Article  |  Next Article 

J. Virol., 07 1996, 4352-4360, Vol 70, No. 7
Copyright © 1996, American Society for Microbiology

Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture

I Bahner, K Kearns, QL Hao, EM Smogorzewska and DB Kohn
Department of Pediatrics, University of Southern California School of Medicine, California 90027, USA.

Genetic modification of hematopoietic stem cells with a synthetic "anti- human immunodeficiency virus type 1 (HIV-1) gene" which inhibits replication of HIV-1 may allow production of mature lymphoid and monocytic cells resistant to HIV-1 growth after autologous transplantation. Because productive HIV-1 replication requires binding of the Rev protein to the Rev-responsive element (RRE) within the viral transcripts for the HIV-1 structural proteins, anti-HIV-1 gene products which interfere with Rev-RRE interactions may inhibit HIV-1 replication. One such strategy involves overexpression of the RRE sequences in transcripts derived from retroviral vectors to act as decoys to sequester Rev protein and prevent its binding to the RRE element in HIV-1 transcripts. We developed an in vitro model to test the efficacy of this gene therapy approach in primary human hematopoietic cells. Human CD34+ hematopoietic progenitor cells from normal bone marrow or umbilical cord blood were transduced with retroviral vectors carrying RRE decoy sequences as part of a long terminal repeat-directed transcript expressing the neo gene (L-RRE-neo) or with a control vector expressing only the neo gene (LN). The transduced progenitors were allowed to differentiate into mature myelomonocytic cells which were able to support vigorous growth of the monocytotropic isolate of HIV-1, JR-FL. HIV-1 replication was measured in unselected cell populations and following G418 selection to obtain uniformly transduced cell populations. Inhibition of HIV-1 replication in the unselected cell cultures was between 50.2 and 76.7% and was highly effective (99.4 to 99.9%) in the G418-selected cultures. Progenitors transduced by either the L-RRE-neo vector or the control LN vector were identical with respect to hematopoietic growth and differentiation. These findings demonstrate the ability of an RRE decoy strategy to inhibit HIV-1 replication in primary human myelomonocytic cells after transduction of CD34+ progenitor cells, without adverse effects on hematopoietic cell function.

This article has been cited by other articles:

• Bartlett, D. W., Davis, M. E. (2006). Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res 34: 322-333 [Abstract] [Full Text]  
• Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., Triche, T. J. (2005). Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma. Cancer Res. 65: 8984-8992 [Abstract] [Full Text]  
• Wang, X., Rosol, M., Ge, S., Peterson, D., McNamara, G., Pollack, H., Kohn, D. B., Nelson, M. D., Crooks, G. M. (2003). Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 102: 3478-3482 [Abstract] [Full Text]  
• Chaloin, L., Lehmann, M. J., Sczakiel, G., Restle, T. (2002). Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1. Nucleic Acids Res 30: 4001-4008 [Abstract] [Full Text]  
• Fisher, T. S., Joshi, P., Prasad, V. R. (2002). Mutations That Confer Resistance to Template-Analog Inhibitors of Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Lead to Severe Defects in HIV Replication. J. Virol. 76: 4068-4072 [Abstract] [Full Text]  
• Kohn, D. B., Bauer, G., Rice, C. R., Rothschild, J.C., Carbonaro, D. A., Valdez, P., Hao, Q.-l., Zhou, C., Bahner, I., Kearns, K., Brody, K., Fox, S., Haden, E., Wilson, K., Salata, C., Dolan, C., Wetter, C., Aguilar-Cordova, E., Church, J. (1999). A Clinical Trial of Retroviral-Mediated Transfer of a rev-Responsive Element Decoy Gene Into CD34+ Cells From the Bone Marrow of Human Immunodeficiency Virus-1-Infected Children. Blood 94: 368-371 [Abstract] [Full Text]  
• Morishita, R., Higaki, J., Tomita, N., Ogihara, T. (1998). Application of Transcription Factor "Decoy" Strategy as Means of Gene Therapy and Study of Gene Expression in Cardiovascular Disease. Circ. Res. 82: 1023-1028 [Abstract] [Full Text]  
• Rosenzweig, M., Marks, D. F., Hempel, D., Heusch, M., Kraus, G., Wong-Staal, F., Johnson, R. P. (1997). Intracellular Immunization of Rhesus CD34+ Hematopoietic Progenitor Cells With a Hairpin Ribozyme Protects T Cells and Macrophages From Simian Immunodeficiency Virus Infection. Blood 90: 4822-4831 [Abstract] [Full Text]  
• Bahner, I., Kearns, K., Coutinho, S., Leonard, E. H., Kohn, D. B. (1997). Infection of Human Marrow Stroma by Human Immunodeficiency Virus-1 (HIV-1) Is Both Required and Sufficient for HIV-1-Induced Hematopoietic Suppression In Vitro: Demonstration by Gene Modification of Primary Human Stroma. Blood 90: 1787-1798 [Abstract] [Full Text]  
• Bagnis, C., Mannoni, P. (1997). Stem Cell-Based Gene Therapy. The Oncologist 2: 196-202 [Full Text]  
• Bauer, G., Valdez, P., Kearns, K., Bahner, I., Wen, S. F., Zaia, J. A., Kohn, D. B. (1997). Inhibition of Human Immunodeficiency Virus-1 (HIV-1) Replication After Transduction of Granulocyte Colony-Stimulating Factor-Mobilized CD34+ Cells From HIV-1-Infected Donors Using Retroviral Vectors Containing Anti-HIV-1 Genes. Blood 89: 2259-2267 [Abstract] [Full Text]